Seaport Therapeutics, Inc. Common Stock

Seaport Therapeutics, Inc. (SPTX) is an innovative biopharmaceutical company focused on the development of cutting-edge immune-oncology therapies aimed at addressing crucial unmet medical needs, particularly in oncology. Leveraging state-of-the-art technologies and an extensive research pipeline, Seaport is committed to creating targeted treatment options for complex diseases, with a specific emphasis on cancer. The company fosters strategic collaborations that augment its capabilities in the rapidly evolving therapeutics landscape, supported by a seasoned management team dedicated to enhancing patient outcomes. With a strong emphasis on scientific innovation and patient impact, Seaport Therapeutics is strategically positioned to influence the future of cancer treatment and immunotherapy.

Sector

Healthcare

Industry

Biotechnology

Country

USA

Fiscal year end

December

Website

seaporttx.com